🔬Excited to share our new publication in
@natcomms.nature.com, presenting large-scale case-control evidence for BRCA1/2 variant classification
💡A major step forward in reducing VUS uncertainty in hereditary breast & ovarian cancer
🌍 Incredible teamwork across international consortia